ENTITY
Shinpoong Pharmaceutical

Shinpoong Pharmaceutical (019170 KS)

79
Analysis
Health Care • South Korea
Shin Poong Pharmaceutical Co., Ltd. manufactures pharmaceutical raw materials and prescription drugs, such as cephalosporin antibiotics, hemostatics, sedative agents, and anti-diabetics.
more
bullish•Hotel Shilla
•09 Feb 2022 15:24

KOSPI Size Index Series Rebalancing Screening Results

This post has the screening results of the KOSPI Size Index Series rebalancing: 14 new MidCap entrants are expected to have a sizable passive impact.

Logo
458 Views
Share
•07 Jan 2022 00:54

Shinpoong Pharmaceutical (019170 KS): Three Concerns Are Clouding the Upside Potential

Concerns regarding the slush fund is the major overhang on the stock price. Oral COVID-19 drug development cannot be considered a major catalyst...

Logo
488 Views
Share
bearish•BNC Korea
•29 Oct 2021 22:50

BNC Korea (256840 KS): Oral COVID-19 Treatment No More Remains a Catalyst

In-licensed oral COVID-19 treatment no longer remains a catalyst after competitor's encouraging clinical trial results. Other oral treatments are...

Logo
258 Views
Share
bearish•LG Display
•30 Sep 2021 19:22

Local Institutions Drive Higher Shorts in KOSPI

In this insight, we discuss the top 10 most heavily shorted stocks in KOSPI (amount shorted/market cap).These heavily shorted stocks have...

Logo
468 Views
Share
•11 Sep 2021 05:48

Asia Shorts: Meituan, CMB, Li Ning, Sekisui, Toyo Seikan, Toshiba, Kakao, HMM, LGE, Wan Hai, TSMC

The Insight looks at movements in short interest across HK, Japan, Korea and Taiwan stocks and highlights large increases/decreases in shorts to...

Logo
353 Views
Share
x